https://www.ema.europa.eu/en/homepageNew human medicinesen-gbCopyright: (C) European Medicines AgencyFri, 10 May 2024 03:35:03 +0200Fri, 26 Apr 2024 12:50:56 +0200https://www.ema.europa.eu/en/medicines/human/variation/alecensaSummary of opinion: Alecensa, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/alecensaFri, 26 Apr 2024 12:50:56 +0200New medicines and SMOPs: humanhttps://www.ema.europa.eu/en/medicines/human/variation/triumeqSummary of opinion: Triumeq, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/triumeqFri, 26 Apr 2024 12:00:00 +0200New medicines and SMOPs: humanhttps://www.ema.europa.eu/en/medicines/human/variation/rozlytrekSummary of opinion: Rozlytrek, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/rozlytrekFri, 26 Apr 2024 12:00:00 +0200New medicines and SMOPs: humanhttps://www.ema.europa.eu/en/medicines/human/variation/rybrevantSummary of opinion: Rybrevant, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/rybrevantFri, 26 Apr 2024 12:00:00 +0200New medicines and SMOPs: humanhttps://www.ema.europa.eu/en/medicines/human/variation/reyatazSummary of opinion: Reyataz, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/reyatazFri, 26 Apr 2024 12:00:00 +0200New medicines and SMOPs: humanhttps://www.ema.europa.eu/en/medicines/human/variation/sirturoSummary of opinion: Sirturo, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/sirturoFri, 26 Apr 2024 12:00:00 +0200New medicines and SMOPs: humanhttps://www.ema.europa.eu/en/medicines/human/variation/opdivo-3Summary of opinion: Opdivo, 25/04/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/opdivo-3Fri, 26 Apr 2024 12:00:00 +0200New medicines and SMOPs: human